| Trial ID: | L1976 |
| Source ID: | NCT01121276
|
| Associated Drug: |
Faster-Acting Insulin Aspart
|
| Title: |
A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Faster-acting insulin aspart|DRUG: insulin aspart|DRUG: Faster-acting insulin aspart|DRUG: Faster-acting insulin aspart|DRUG: Faster-acting insulin aspart
|
| Outcome Measures: |
Primary: Area under the blood glucose concentration-time curve, from 0-2 hours | Secondary: Area under the blood glucose concentration-time curve, from 0-6 hours
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
82
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-04
|
| Completion Date: |
2010-09
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-18
|
| Locations: |
Novo Nordisk Investigational Site, Chula Vista, California, 91911, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01121276
|
